The long-term goal of this research is to understand the unique role of proteins encoded by the major histocompatibility complex (MHC) in T cell recognition and activation. The murine cytotoxic T cell (CTL) response to allogeneic class I H-2 molecules is 2 to 3 orders of magnitude greater than the response to xenogeneic class I HLA molecules. This has been shown to reflect structural differences between H-2 and HLA molecules and not expression on cells of different species. Indeed, HLA antigens expressed on murine cells are recognized preferentially as nominal antigens in the context of H-2 molecules. A possible explanation for these observations is that during T cell ontogeny, the T cell repertoire develops to recognize epitopes that closely resemble syngeneic H- 2 molecules. Therefore, CTL recognize allogeneic epitopes more easily than xenogeneic epitopes. Another explanation is that MHC antigens bear conserved determinant(s) that mark them as ligands for T cells. T cells might not interact as well with xenogeneic MHC antigens if such determinants had undergone evolutionary modification. Recognition of such determinants could occur either through the T cell receptor, or through accessory molecules such as CD8. In the proposed work, these possible explanations will be distinguished by the use of transgenic mice expressing either human class I MHC or CD8 molecules or both. The influence of expression of the molecules on: a) The frequency of HLA specific precursors; b) The utilization of HLA antigens as restricting elements; and c) T cell receptor gene usage in HLA-specific responses, will be examined. In addition, the nature of structural differences between HLA and H-2 molecules that are relevant to their recognition by murine T cell will be evaluated by the construction of chimeric HLA/H-2 molecules and determination of their ability to elicit T cell responses. These chimeric molecules will also be used to evaluate the nature of the HLA determinants recognized by H-2 restricted murine CTL. These studies are expected to increase understanding of the role of species-specific structures on MHC antigens, T cell receptors, and/or accessory molecules in T cell recognition and the development of the T cell repertoire. They should also contribute to knowledge concerning the structural features on T cell receptors that mediate antigen recognition, and the nature of processed antigens that become associated with class I MHC products.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI021393-09
Application #
3131472
Study Section
Immunobiology Study Section (IMB)
Project Start
1984-07-01
Project End
1994-06-30
Budget Start
1992-07-01
Budget End
1994-06-30
Support Year
9
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Engelhard, Victor H; Altrich-Vanlith, Michelle; Ostankovitch, Marina et al. (2006) Post-translational modifications of naturally processed MHC-binding epitopes. Curr Opin Immunol 18:92-7
Bullock, Timothy N J; Mullins, David W; Engelhard, Victor H (2003) Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells. J Immunol 170:1822-9
Bullock, T N; Mullins, D W; Colella, T A et al. (2001) Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice. J Immunol 167:5824-31
Luckey, C J; Marto, J A; Partridge, M et al. (2001) Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J Immunol 167:1212-21
Bullock, T N; Colella, T A; Engelhard, V H (2000) The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. J Immunol 164:2354-61
Colella, T A; Bullock, T N; Russell, L B et al. (2000) Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. J Exp Med 191:1221-32
Crotzer, V L; Christian, R E; Brooks, J M et al. (2000) Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. J Immunol 164:6120-9
Slingluff Jr, C L; Colella, T A; Thompson, L et al. (2000) Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunol Immunother 48:661-72
Sarobe, P; Pendleton, C D; Akatsuka, T et al. (1998) Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. J Clin Invest 102:1239-48
Mosse, C A; Meadows, L; Luckey, C J et al. (1998) The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med 187:37-48

Showing the most recent 10 out of 41 publications